FPF
DARE icon

First Pacific Financial’s Dare Bioscience DARE Stock Holding History

First Pacific Financial’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-833
Closed -$4.9K – 401
2024
Q1 		$4.9K Hold
833
– – ﹤0.01% 297
2023
Q4 		$3.09K Buy
+833
New +$3.81K ﹤0.01% 292

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

First Pacific Financial's DARE Position: Q2 2024 in Review

First Pacific Financial sold out of Dare Bioscience (DARE) in Q2 2024, closing a stake of 833 shares — an estimated $4.9K sold.

First Pacific Financial first reported a position in DARE in Q4 2023 and held it in 2 quarters. The position peaked at $4.9K in Q1 2024. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2024.

  • First Pacific Financial reported no remaining Dare Bioscience position as of Q2 2024 after selling out during the quarter.
  • First Pacific Financial sold 833 Dare Bioscience shares in Q2 2024, an estimated $4.9K.
  • First Pacific Financial first reported a position in Dare Bioscience in Q4 2023 and held it in 2 quarters.
  • First Pacific Financial's Dare Bioscience position peaked at $4.9K in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2024.

Based on First Pacific Financial's 13F filing for Q2 2024, filed 19 Jul 2024.